CoChat

Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics

Korzhnev, Dmitry M., Hadden, M. Kyle · 2016 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.

Abstract

Human cells possess tightly controlled mechanisms to rescue DNA replication following DNA damage caused by environmental and endogenous carcinogens using a set of low-fidelity translesion synthesis (TLS) DNA polymerases. These polymerases can copy over replication blocking DNA lesions while temporarily leaving them unrepaired, preventing cell death at the expense of increasing mutation rates and contributing to the onset and progression of cancer. In addition, TLS has been implicated as a major cellular mechanism promoting acquired resistance to genotoxic chemotherapy. Owing to its central role in mutagenesis and cell survival after DNA damage, inhibition of the TLS pathway has emerged as a potential target for the development of anticancer agents. This review will recap our current understanding of the structure and regulation of DNA polymerase complexes that mediate TLS and describe how this knowledge is beginning to translate into the development of small molecule TLS inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.6b00596

Cites

181 of 181 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 181 references

Cited by

See all 62

Metadata

Authors
Korzhnev, D. M., & Hadden, M. K.
Affiliations
  • UConn Health (US)
  • University of Connecticut (US)
Corresponding author
  • Korzhnev, Dmitry M.
  • Hadden, M. Kyle
Venue
Journal of Medicinal Chemistry
Published
2016-07-19
Volume
59
Issue
20
Pages
9321-9336
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2466355266
Cited by
58
References
181
Citations by year
2026: 4 · 2025: 4 · 2024: 7 · 2023: 4 · 2022: 1 · 2021: 6 · 2020: 10 · 2019: 7 · 2018: 3 · 2017: 12
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (CA190617)
  • Division of Molecular and Cellular Biosciences (1515808)
  • American Cancer Society (RSG-13-131-01)
  • University of Connecticut Health Center
  • University of Connecticut Research Foundation
  • Connecticut Institute for Clinical and Translational Science, University of Connecticut
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
translesion synthesis, DNA polymerase, DNA damage, mutagenesis, chemoresistance, DNA replication, small molecule inhibitors
MeSH terms
Animals, Antineoplastic Agents, Cell Survival, DNA Damage, DNA-Directed DNA Polymerase, Dose-Response Relationship, Drug, Humans, Neoplasms, Structure-Activity Relationship, Molecular Structure, Small Molecule Libraries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics. https://app.cochat.ai/papers/10.1021/acs.jmedchem.6b00596
The paper
Korzhnev, D. M., & Hadden, M. K. (2016). Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6b00596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.